Skip to content

Effect of different doses of remimazolam on anesthesia depth index during anesthesia induction period for gynecological day surgery

Effect of different doses of remimazolam on anesthesia depth index during anesthesia induction period for gynecological day surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100940
Enrollment
Unknown
Registered
2025-04-17
Start date
2024-08-23
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

R1 Group:Remimazolam 0.10 mg/kg is given for anesthesia induction.
R2 Group:Remimazolam 0.15 mg/kg is given for anesthesia induction.
R3 Group:Remimazolam 0.20 mg/kg is given for anesthesia induction.
R4 Group:Remimazolam 0.25 mg/kg is given for anesthesia induction.
R5 Group:Remimazolam 0.30 mg/kg is given for anesthesia induction.
R6 Group:Remimazolam 0.35 mg/kg is given for anesthesia induction.
R7 Group:Remimazolam 0.40 mg/kg is given for anesthesia induction.

Sponsors

Weifang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Patients who choose to undergo hysteroscopy, cervical conization, or other gynaecological day surgery at our hospital. 2. ASA classification I-II. 3. Females aged 18-64 years. 4.Sign the informed consent for anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to benzodiazepines and any components of this product. 2. Patients with myasthenia gravis. 3. Patients with schizophrenia and severe depression. 4. Pathological obesity/obstructive sleep apnea. 5. Acute upper respiratory tract infection. 6. Asthma attack period. 7. Uncontrolled severe hypertension. 8. Unstable angina. 9. Severe liver dysfunction. 10. Acute upper gastrointestinal bleeding with shock. 11. Severe anemia. 12. Gastrointestinal obstruction with retention of gastric contents. 13. Long-term sedative and analgesic drug use history and allergic history. 14. There are contraindications to anesthesia.

Design outcomes

Primary

MeasureTime frame
Ai index 2 min after anesthesia induction;Change in Ai in 5 minutes;

Secondary

MeasureTime frame
Induction period and intraoperative incidence of adverse events;Anesthesia maintenance and recovery time;General information of the patient;Changes in hemodynamics during anesthesia;Intraoperative Ai indicators;Reimazolam and alfentanil dosage;

Countries

China

Contacts

Public ContactFanceng Ji

Weifang People's Hospital

jifanceng@163.com+86 135 6369 8838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026